Schedule 13D ownership disclosure

PROVECTUS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 74373F100

Event date: 2017-04-14

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
0.5300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-126185
Form type
SC 13D/A
Filer
MILLER COURTLANDT G
CIK
CIK 901585
Filed
Apr 17, 2017
Reporting period
Apr 14, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub